TY - JOUR
T1 - Dual enzymes-mimic activity of nanolayered manganese-calcium oxide for fluorometric determination of metformin
AU - Rashtbari, Samaneh
AU - Dehghan, Gholamreza
AU - Khataee, Simin
AU - Amini, Mojtaba
AU - Khataee, Alireza
N1 - Publisher Copyright:
© 2021 Elsevier Ltd
PY - 2022/3
Y1 - 2022/3
N2 - There are different analytical methods available for the determination of metformin, as an oral hypoglycemic and antidiabetic drug, in biological samples. However, most of these methods suffer from some drawbacks, including high-priced materials and equipment, damaging chemical reagents, time-consuming nature, and tedious operation procedures. So, in this work a new, sensitive and simple method was reported for the detection of metformine. In this regard, nanolayered manganese-calcium oxide (NL-MnCaO2) were synthesized and characterized using scanning electron microscopy (SEM), fourier transform infrared (FTIR) spectroscopy, and X-ray powder diffraction (XRD) techniques. Also, we studied the enzyme-like activity of synthesized particles and reported a bifunctional nanozyme, which performs the dual roles for peroxidase and catalase-mimicking. The results demonstrated the hindering effect of metformin on the peroxidase-mimic activity of NL-MnCaO2 and this effect was increased by raising metformin concentration. So, a sensitive fluorometric detection system was designed for the analytical assay of metformin, based on the terephthalic acid (TA)-H2O2 reaction with NL-MnCaO2. An acceptable linearity was observed between the metformin concentration and fluorescence quenching of the system in the range of 0.07–0.77 mM. Limit of detection (LOD) and limit of quantification (LOQ) were 0.17 μM and 0.96 μM, respectively. The proposed system was applied for the estimation of metformin concentration in serum samples by recoveries of 86.68–106%. So, the proposed fluorometric method provides some main advantages such as wide linear range, low detection limit, rapid detections, high sensitivity, and good practicability for the determination of metformin in biological samples.
AB - There are different analytical methods available for the determination of metformin, as an oral hypoglycemic and antidiabetic drug, in biological samples. However, most of these methods suffer from some drawbacks, including high-priced materials and equipment, damaging chemical reagents, time-consuming nature, and tedious operation procedures. So, in this work a new, sensitive and simple method was reported for the detection of metformine. In this regard, nanolayered manganese-calcium oxide (NL-MnCaO2) were synthesized and characterized using scanning electron microscopy (SEM), fourier transform infrared (FTIR) spectroscopy, and X-ray powder diffraction (XRD) techniques. Also, we studied the enzyme-like activity of synthesized particles and reported a bifunctional nanozyme, which performs the dual roles for peroxidase and catalase-mimicking. The results demonstrated the hindering effect of metformin on the peroxidase-mimic activity of NL-MnCaO2 and this effect was increased by raising metformin concentration. So, a sensitive fluorometric detection system was designed for the analytical assay of metformin, based on the terephthalic acid (TA)-H2O2 reaction with NL-MnCaO2. An acceptable linearity was observed between the metformin concentration and fluorescence quenching of the system in the range of 0.07–0.77 mM. Limit of detection (LOD) and limit of quantification (LOQ) were 0.17 μM and 0.96 μM, respectively. The proposed system was applied for the estimation of metformin concentration in serum samples by recoveries of 86.68–106%. So, the proposed fluorometric method provides some main advantages such as wide linear range, low detection limit, rapid detections, high sensitivity, and good practicability for the determination of metformin in biological samples.
KW - Dual-enzyme mimetic activity
KW - Fluorometric method
KW - Manganese-calcium oxide
KW - Metformin
UR - http://www.scopus.com/inward/record.url?scp=85120643707&partnerID=8YFLogxK
U2 - 10.1016/j.chemosphere.2021.133063
DO - 10.1016/j.chemosphere.2021.133063
M3 - Article
C2 - 34848228
AN - SCOPUS:85120643707
SN - 0045-6535
VL - 291
JO - Chemosphere
JF - Chemosphere
M1 - 133063
ER -